【摘 要】
：
Postoperative non-small cell lung cancer (NSCLC) patients require adjuvant therapy to improve their prognosis.In this study, we investigated the efficacy of a sequential combination of cellular immuno
【机 构】
：
Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China
论文部分内容阅读
Postoperative non-small cell lung cancer (NSCLC) patients require adjuvant therapy to improve their prognosis.In this study, we investigated the efficacy of a sequential combination of cellular immunotherapy (CIT) and chemotherapy for postoperative NSCLC.
其他文献
目的：评估先天性心脏病患儿PetCO2、TcpCO2与PaCO2值的相关性和一致性。方法：选取80例先天性心脏病在体外循环下手术的患儿,年龄从1月～5岁,分四组(每组各20例)：N1组紫绀型伴严重的肺高压；N2组紫绀型不伴肺高压；N3组非紫绀型伴严重的肺高压或肺血流增加；N4组非紫绀型伴轻度的肺高压或肺动脉压力正常。统一选取相同的麻醉方案,在手术开始前记录患儿的PetCO2、TcpCO2与PaCO
目的：观察单纯丙泊酚静脉麻醉用于无痛胃镜检查的安全性和效果.方法：选择2013年1月至2014年8月在本院内镜中心进行无痛胃镜检查的患者1190例,年龄在16-70岁,ASA分级Ⅰ～Ⅱ级.全部采用单纯丙泊酚静脉麻醉方式,检查前开放上肢静脉,鼻导管吸氧(2-4L/min),监测患者血压(BP)、心率(HR)、脉氧饱和度(SPO2),心电图检查有异常的患者加ECG监测.结果：3例患者发生喉痉挛,其中2
背景与目的：程序性死亡蛋白1 (programmed death protein 1,PD-1)和它的配体(programmed death-ligand 1,PD-L1)在肿瘤免疫中发挥重要作用。本研究旨在探究PD-L1蛋白在胃癌组织中的表达和对胃癌患者预后的预测作用,以及PD-L1表达与肿瘤浸润淋巴细胞(tumor-infiltrating lymphocyte,TIL)浸润的相关性。
胃癌居全球恶性肿瘤发病率第四位。中国每年新增胃癌患者占全球总数的40％，希罗达联合奥沙利铂(XELOX)是胃癌患者的常规化疗药物，但是其化疗效果因人而异，推测与化疗过程中患者不同的免疫格局有关。因此，本研究旨在探讨胃癌患者化疗早期免疫格局和化疗效果的相关性，优化胃癌患者的临床治疗策略。
Myeloid-derived suppressor cells (MDSC) potently inhibit antitumor immune responses, and thereby promoting tumor progression and metastasis.However, the nature of human tumor-infiltrating MDSC remains
B7-H4 was over expressed in many cancers and was associated with clinical progression.Although B7-H4 are most discussed, the regulation mechnisms of B7-H4 during tumor cells are unknown.
Background and Objectives: The objective in present study was to evaluate the potent role of LPA receptors in processes leading to local invasiveness and metastasis in Chinese human ductal adenocarcin
Introduction: Aiming at starting the ball rolling and contributing humble effort to promote Chinese traditional medicine(CTM), we performed the present study to assess the therapy response of Chinese
研究背景：PD-L1分子在肿瘤组织中的表达受到广泛关注,被认为是肿瘤免疫治疗中的重要靶点。作为严重影响妇女健康的重大疾病——卵巢癌,PD-L1和其发生发展的研究有待进一步加强。目的：本研究旨在探讨PD-L1分子在人卵巢癌组织中的表达特点及其和免疫细胞亚群浸润、癌细胞上Ki-67等分子表达的关系,揭示其在卵巢癌组织中表达的生物学和临床意义。
Introduction: Aiming at starting the ball rolling and contributing humble effort to promote Chinese traditional medicine(CTM), we performed the present study to assess the therapy response of Chinese